Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grum, C. M.
Right arrow Articles by Fox, I. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grum, C. M.
Right arrow Articles by Fox, I. H.

Chest, Vol 88, 763-767, Copyright © 1985 by American College of Chest Physicians

ARTICLES

Evidence for adenosine triphosphate degradation in critically-ill patients

CM Grum, RH Simon, DR Dantzker and IH Fox

Alterations of cellular energy metabolism may provide important markers during the clinical course of critically ill patients. To determine whether adenosine triphosphate (ATP) degradation occurs in critically ill patients, we measured levels of adenosine, inosine, hypoxanthine, and xanthine in 18 patients and seven control subjects. The mean concentration of hypoxanthine (3.8 microM) in the critically ill patients was elevated (p less than 0.01) compared to that of our control population (0.1 microM). A subgroup of seven critically ill patients had levels of hypoxanthine, xanthine, or inosine higher than those of any member of the control group. This subgroup was characterized by a lower systolic blood pressure, an increased requirement for vasopressors, and a markedly decreased survival rate when compared to the other critically ill patients. Arterial and mixed venous blood gas values were not helpful in predicting survival and did not correlate with levels of ATP degradation products. In two patients who showed subsequent clinical improvement, the initially elevated levels of hypoxanthine and xanthine returned to normal. This study indicates that critically ill patients have elevated levels of ATP degradation products. These increased levels may indicate cellular hypoxia.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
G. Hasko, D. G. Kuhel, Z. H. Nemeth, J. G. Mabley, R. F. Stachlewitz, L. Virag, Z. Lohinai, G. J. Southan, A. L. Salzman, and C. Szabo
Inosine Inhibits Inflammatory Cytokine Production by a Posttranscriptional Mechanism and Protects Against Endotoxin-Induced Shock
J. Immunol., January 15, 2000; 164(2): 1013 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
G. Supinski, D. Nethery, D. Stofan, L. Szweda, and A. DiMarco
Oxypurinol administration fails to prevent free radical-mediated lipid peroxidation during loaded breathing
J Appl Physiol, September 1, 1999; 87(3): 1123 - 1131.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
E. J. Pesonen, K. I. Peltola, R. E. Korpela, H. I. Sairanen, M. A. Leijala, K. O. Raivio, and S. H.M. Andersson
Delayed impairment of cerebral oxygenation after deep hypothermic circulatory arrest in children
Ann. Thorac. Surg., June 1, 1999; 67(6): 1765 - 1770.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. SAITO, M. NISHIMURA, H. SHINANO, H. MAKITA, I. TSUJINO, E. SHIBUYA, F. SATO, K. MIYAMOTO, and Y. KAWAKAMI
Plasma Concentration of Adenosine during Normoxia and Moderate Hypoxia in Humans
Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 1014 - 1018.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American College of Chest Physicians.